Back
Cytokinetics Stock Price Chart

Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
20
CYTK
Cytokinetics
Last Price:
$39.14
Seasonality Move:
9.11%
7 Day Trial
ALL ACCESS PASS
$
7

He's already IPO'd once - this time's different
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.
Cytokinetics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.81 | Buy |
20-day SMA: | 41.07 | Sell |
50-day SMA: | 43.89 | Sell |
200-day SMA: | 50.81 | Sell |
8-day EMA: | 37.58 | Buy |
20-day EMA: | 32.09 | Buy |
50-day EMA: | 19.74 | Buy |
200-day EMA: | 6.32 | Buy |
Cytokinetics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 7.51 | Buy |
Relative Strength Index (14 RSI): | 43.16 | Sell |
Chaikin Money Flow: | 1256338 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.39 - 44.97) | Sell |
Bollinger Bands (100): | (42.44 - 50.64) | Sell |
Cytokinetics Technical Analysis
Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cytokinetics Stock
Is Cytokinetics Stock a Buy?
-
Cytokinetics share price is 38.65 while CYTK 8-day simple moving average is 37.81, which is a Buy signal.
-
The stock price of CYTK is 38.65 while Cytokinetics 20-day SMA is 41.07, which makes it a Sell.
-
Cytokinetics 50-day simple moving average is 43.89 while CYTK share price is 38.65, making it a Sell technically.
-
CYTK stock price is 38.65 and Cytokinetics 200-day simple moving average is 50.81, creating a Sell signal.
CYTK Technical Analysis vs Fundamental Analysis
Sell
20
Cytokinetics (CYTK)
is a Sell
Is Cytokinetics a Buy or a Sell?
-
Cytokinetics stock is rated a SellThe current Cytokinetics [CYTK] share price is $38.65. The Score for CYTK is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Cytokinetics Stock Info
Market Cap:
4.6B
Price in USD:
38.65
Share Volume:
2.5M
Cytokinetics 52-Week Range
52-Week High:
73.76
52-Week Low:
32.74
Sell
20
Cytokinetics (CYTK)
is a Sell
Cytokinetics Share Price Forecast
-
What is the Cytokinetics stock price today?The Cytokinetics stock price is 38.65 USD today.
-
Will CYTK stock go up or go down?Cytokinetics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cytokinetics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cytokinetics is overvalued.
Is Cytokinetics Stock a Buy?
-
Cytokinetics share price is 38.65 while CYTK 8-day exponential moving average is 37.58, which is a Buy signal.
-
The stock price of CYTK is 38.65 while Cytokinetics 20-day EMA is 32.09, which makes it a Buy.
-
Cytokinetics 50-day exponential moving average is 19.74 while CYTK share price is 38.65, making it a Buy technically.
-
CYTK stock price is 38.65 and Cytokinetics 200-day simple moving average is 6.32, creating a Buy signal.
Fundamental Analysis of Cytokinetics
Is Cytokinetics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.27 per share, a decrease this year of $0.46 per share, and an increase next year of $0.70 per share.
Technical Analysis of Cytokinetics
Should I short Cytokinetics stock?
-
CYTK Moving Average Covergence Divergence (MACD) indicator is 7.51, suggesting Cytokinetics is a Buy
-
Cytokinetics Relative Strength Index (RSI) is 43.16, which suggest Cytokinetics is oversold
-
The Bollinger Bands (25) for Cytokinetics is (38.39 - 44.97), which suggest Cytokinetics is a Sell
-
The Bollinger Bands (100) for Cytokinetics is (42.44 - 50.64), which suggest Cytokinetics is a Sell
* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.